English version of the self-administered Fabry Pain Questionnaire for adult patients.
English version
Fabry disease
Fabry-associated pain
Pain questionnaire
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
20 10 2020
20 10 2020
Historique:
received:
20
06
2020
accepted:
13
10
2020
entrez:
21
10
2020
pubmed:
22
10
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Pain is an early symptom of Fabry disease (FD) and is characterized by a unique phenotype with mainly episodic acral and triggerable burning pain. Recently, we designed and validated the first pain questionnaire for adult FD patients in an interview and a self-administered version in German: the Würzburg Fabry Pain Questionnaire (FPQ). We now report the validation of the English version of the self-administered FPQ (enFPQ). After two forward-backward translations of the FPQ by native German and native English speakers, the enFPQ was applied at The Mark Holland Metabolic Unit, Manchester, UK for validation. Consecutive patients with genetically ascertained FD and current or previous FD pain underwent a face-to-face interview using the enFPQ. Two weeks later, patients filled in the self-administered enFPQ at home. The agreement between entries collected by supervised administration and self-administration of the enFPQ was assessed via Gwet's AC1-statistics (AC1) for nominal-scaled scores and intraclass correlation coefficient (ICC) for interval-scaled elements. Eighty-three FD patients underwent the face-to-face interview and 54 patients sent back a completed self-administered version of the enFPQ 2 weeks later. We found high agreement with a mean AC1-statistics of 0.725 for 55 items, and very high agreement with a mean ICC of 0.811 for 9 items. We provide the validated English version of the FPQ for self-administration in adult FD patients. The enFPQ collects detailed information on the individual FD pain phenotype and thus builds a solid basis for better pain classification and treatment in patients with FD.
Sections du résumé
BACKGROUND
Pain is an early symptom of Fabry disease (FD) and is characterized by a unique phenotype with mainly episodic acral and triggerable burning pain. Recently, we designed and validated the first pain questionnaire for adult FD patients in an interview and a self-administered version in German: the Würzburg Fabry Pain Questionnaire (FPQ). We now report the validation of the English version of the self-administered FPQ (enFPQ).
METHODS
After two forward-backward translations of the FPQ by native German and native English speakers, the enFPQ was applied at The Mark Holland Metabolic Unit, Manchester, UK for validation. Consecutive patients with genetically ascertained FD and current or previous FD pain underwent a face-to-face interview using the enFPQ. Two weeks later, patients filled in the self-administered enFPQ at home. The agreement between entries collected by supervised administration and self-administration of the enFPQ was assessed via Gwet's AC1-statistics (AC1) for nominal-scaled scores and intraclass correlation coefficient (ICC) for interval-scaled elements.
RESULTS
Eighty-three FD patients underwent the face-to-face interview and 54 patients sent back a completed self-administered version of the enFPQ 2 weeks later. We found high agreement with a mean AC1-statistics of 0.725 for 55 items, and very high agreement with a mean ICC of 0.811 for 9 items.
CONCLUSIONS
We provide the validated English version of the FPQ for self-administration in adult FD patients. The enFPQ collects detailed information on the individual FD pain phenotype and thus builds a solid basis for better pain classification and treatment in patients with FD.
Identifiants
pubmed: 33081835
doi: 10.1186/s13023-020-01580-9
pii: 10.1186/s13023-020-01580-9
pmc: PMC7576746
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
296Références
Orphanet J Rare Dis. 2015 Sep 17;10:113
pubmed: 26381732
N Engl J Med. 2001 Jul 5;345(1):9-16
pubmed: 11439963
J Peripher Nerv Syst. 2011 Dec;16(4):304-14
pubmed: 22176145
Eur J Pain. 2011 Sep;15(8):822-9
pubmed: 21334933
Fortschr Neurol Psychiatr. 2010 Jun;78(6):355-9
pubmed: 20411481
JAMA. 2001 Jun 6;285(21):2743-9
pubmed: 11386930
J Inherit Metab Dis. 2014 Mar;37(2):177-87
pubmed: 23949010
Pain. 1992 Aug;50(2):133-49
pubmed: 1408309
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
N Engl J Med. 2016 Aug 11;375(6):545-55
pubmed: 27509102
Clin Neurophysiol. 2008 Jun;119(6):1365-72
pubmed: 18387337
Health Qual Life Outcomes. 2012 Sep 20;10:116
pubmed: 22992222
Clin J Pain. 2014 Oct;30(10):915-20
pubmed: 24121530
Pain. 2004 Apr;108(3):248-57
pubmed: 15030944
Pain. 2014 Nov;155(11):2301-5
pubmed: 25168668
Muscle Nerve. 2010 Mar;41(3):409-12
pubmed: 20120004
Pain. 2009 Sep;145(1-2):237-45
pubmed: 19665302
Curr Opin Neurol. 2011 Oct;24(5):463-8
pubmed: 21825987